-
Mashup Score: 0JNCCN 360 - B-Cell Lymphomas - AACR 2023: Can Machine Learning Improve Predictive Prognostics in Mantle Cell Lymphoma? - 10 month(s) ago
By: Joshua Swore, PhD Posted: Monday, May 8, 2023 A call to build more advanced machine learning models that use numerous features from molecular and genomic data was presented at the American Association for Cancer Research Annual Meeting 2023 (Abstract 5377/26). “Current prognostic indicators, such as the [Mantle…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Phase I trial of NVG-111, a ROR1-targeting BiTE alone or with ibrutinib in R/R CLL & MCL - 1 year(s) ago
Parag Jasani, MBBS, MRCP, FRCPath, FRCP, University College London Hospital, London, UK, briefly summarizes preliminary data from a Phase I…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
In this video, Tycel Phillips, MD, University of Michigan, Ann Arbor, MI, highlights some of the most promising therapies for…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Patients with relapsed/refractory mantle cell lymphoma experienced promising response rates after undergoing treatment with zanubrutinib.
Source: Cancer NetworkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1CAR-NK and CAR-T for MCL - 3 year(s) ago
Michael L. Wang, MD, MD Anderson Cancer Center, Houston, TX, shares an update on chimeric antigen receptor natural killer cell…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant - 3 year(s) ago
How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant - 3 year(s) ago
How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant - 3 year(s) ago
How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant - 3 year(s) ago
How I treat CLL and MCL: From ‘watch and wait’ to BCL2 and BTK inhibitors, CAR T-cell therapy, and transplant
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
Source: Wiley Online LibraryCategories: Hem/Oncs, Latest HeadlinesTweet
#AACR23: Can #MachineLearning Improve Predictive Prognostics in Mantle Cell #Lymphoma? https://t.co/i4veYijVhi #lymsm #MantleCellLymphoma #MCLsm #JNCCN360 https://t.co/i9nUdr781V